Mitsuko Ideno

590 total citations
9 papers, 479 citations indexed

About

Mitsuko Ideno is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Mitsuko Ideno has authored 9 papers receiving a total of 479 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Immunology, 6 papers in Oncology and 1 paper in Molecular Biology. Recurrent topics in Mitsuko Ideno's work include Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (4 papers). Mitsuko Ideno is often cited by papers focused on Immune Cell Function and Interaction (6 papers), CAR-T cell therapy research (5 papers) and Immunotherapy and Immune Responses (4 papers). Mitsuko Ideno collaborates with scholars based in Japan and United States. Mitsuko Ideno's co-authors include Junichi Mineno, Tatsuji Enoki, Naoyuki Sakamoto, Tetsuya Okayama, Yoshito Itoh, Satoshi Kokura, Yuji Naito, Takeshi Ishikawa, Kaname Oka and Toshikazu Yoshikawa and has published in prestigious journals such as PLoS ONE, Cancer Research and International Journal of Cancer.

In The Last Decade

Mitsuko Ideno

8 papers receiving 460 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mitsuko Ideno Japan 6 409 341 105 30 27 9 479
Jennifer A. Foltz United States 12 410 1.0× 240 0.7× 79 0.8× 61 2.0× 30 1.1× 20 491
Annelisa M. Cornel Netherlands 9 229 0.6× 245 0.7× 164 1.6× 37 1.2× 15 0.6× 16 439
Kirsten Nikolajsen Denmark 11 301 0.7× 213 0.6× 126 1.2× 38 1.3× 52 1.9× 15 401
Soyoko Morimoto Japan 13 209 0.5× 188 0.6× 196 1.9× 21 0.7× 31 1.1× 37 388
Qods Lahmar Belgium 6 527 1.3× 318 0.9× 168 1.6× 21 0.7× 38 1.4× 6 637
Anja Waldmann Germany 5 381 0.9× 369 1.1× 75 0.7× 51 1.7× 41 1.5× 6 468
Theo Nicholaou Australia 5 357 0.9× 259 0.8× 107 1.0× 19 0.6× 10 0.4× 6 431
Maja Todorovic Italy 8 313 0.8× 307 0.9× 66 0.6× 42 1.4× 30 1.1× 11 401
Kyung‐Ok Nam South Korea 6 408 1.0× 240 0.7× 97 0.9× 37 1.2× 6 0.2× 8 513
Sreevani Arisa United States 6 196 0.5× 206 0.6× 164 1.6× 40 1.3× 20 0.7× 11 387

Countries citing papers authored by Mitsuko Ideno

Since Specialization
Citations

This map shows the geographic impact of Mitsuko Ideno's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mitsuko Ideno with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mitsuko Ideno more than expected).

Fields of papers citing papers by Mitsuko Ideno

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mitsuko Ideno. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mitsuko Ideno. The network helps show where Mitsuko Ideno may publish in the future.

Co-authorship network of co-authors of Mitsuko Ideno

This figure shows the co-authorship network connecting the top 25 collaborators of Mitsuko Ideno. A scholar is included among the top collaborators of Mitsuko Ideno based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mitsuko Ideno. Mitsuko Ideno is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Shigematsu, Kazuo, et al.. (2024). “Evaluation of neprilysin activity in Adipose-Derived stem cells from Alzheimer's disease patients”. Neuroscience Letters. 825. 137705–137705.
2.
Shigematsu, Kazuo, et al.. (2023). Repeated intravenous infusion of adipose Tissue-Derived stem cells as a promising treatment for amyotrophic lateral sclerosis. Medical Hypotheses. 181. 111205–111205. 2 indexed citations
3.
Ishikawa, Takeshi, Tetsuya Okayama, Naoyuki Sakamoto, et al.. (2018). Abstract CT147: Safety and efficacy of high purity and activity NK cells therapy in combination with IgG1 antibody in patients with gastric or colorectal cancer: A phase I clinical trial. Cancer Research. 78(13_Supplement). CT147–CT147. 1 indexed citations
4.
Ishikawa, Takeshi, Tetsuya Okayama, Naoyuki Sakamoto, et al.. (2018). Phase I clinical trial of adoptive transfer of expanded natural killer cells in combination with IgG1 antibody in patients with gastric or colorectal cancer. International Journal of Cancer. 142(12). 2599–2609. 92 indexed citations
5.
Sakamoto, Naoyuki, Takeshi Ishikawa, Satoshi Kokura, et al.. (2015). Phase I clinical trial of autologous NK cell therapy using novel expansion method in patients with advanced digestive cancer. Journal of Translational Medicine. 13(1). 277–277. 208 indexed citations
6.
Ishikawa, Takeshi, Satoshi Kokura, Tatsuji Enoki, et al.. (2014). Phase I Clinical Trial of Fibronectin CH296-Stimulated T Cell Therapy in Patients with Advanced Cancer. PLoS ONE. 9(1). e83786–e83786. 20 indexed citations
7.
Ikeda, Hiroaki, Naoko Imai, Linan Wang, et al.. (2014). Stimulation through very late antigen‐4 and ‐5 improves the multifunctionality and memory formation of CD8+ T cells. European Journal of Immunology. 44(6). 1747–1758. 9 indexed citations
8.
Ueda, Yuji, Ichiro Kawashima, Ikuei Nukaya, et al.. (2002). Immunotherapy of solid cancer using dendritic cells pulsed with the HLA-A24-restricted peptide of carcinoembryonic antigen. Cancer Immunology Immunotherapy. 51(2). 99–106. 63 indexed citations
9.
Nukaya, Ikuei, Mitsuko Ideno, Alessandro Sette, et al.. (1999). Identification of HLA-A24 epitope peptides of carcinoembryonic antigen which induce tumor-reactive cytotoxic T lymphocyte. International Journal of Cancer. 80(1). 92–97. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026